Reply to: Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C

被引：0
|
作者：
Sakin, Yusuf Serdar [1 ]
Polat, Zulfikar [1 ]
Demirci, Hakan [1 ]
Kekilli, Murat [2 ]
Uygun, Ahmet [1 ]
Bagci, Sait [1 ]
机构：
[1] Gulhane Mil Med Acad, Dept Gastroenterol, Ankara, Turkey
[2] Hitit Univ, Corum, Turkey
来源：
HEPATOLOGY RESEARCH | 2014年 / 44卷 / 09期
关键词：
D O I：
10.1111/hepr.12278
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1037 / 1037
页数：1
相关论文
共 50 条
  • [41] Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
    Jung, Young Kul
    Kim, Ju Hyun
    CLINICAL AND MOLECULAR HEPATOLOGY, 2013, 19 (01) : 26 - 28
  • [42] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Loustaud-Ratti, Veronique
    Carrier, Paul
    Vong, Chanlina
    Essig, Marie
    HEPATOLOGY, 2014, 59 (06) : 2426 - 2426
  • [43] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir
    Mauss, Stefan
    Hueppe, Dietrich
    Alshuth, Ulrich
    HEPATOLOGY, 2014, 59 (01) : 46 - 48
  • [44] Outcome of Retinopathy in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin
    Mehta, Nilesh
    Murthy, Uma K.
    Kaul, Vivek
    Alpert, Samuel
    Abruzzese, Gerald
    Teitelbaum, Charles
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (02) : 452 - 457
  • [45] Predictors of thyroid dysfunction in patients with chronic hepatitis C during peginterferon and ribavirin combination therapy
    Jang, E. S.
    Kim, W.
    Park, D-J
    Kim, B-H
    Jung, Y-J
    Kim, D-H
    Kim, Y. J.
    Yoon, J-H
    Lee, H-S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A40 - A40
  • [46] Randomized controlled trial of nitazoxanide-peginterferon-ribavirin, nitazoxanide-peginterferon and peginterferon-ribavirin in the treatment of patients with chronic hepatitis C genotype 4
    Rossignol, J. F.
    Elfert, A.
    El-Gohary, Y.
    Keeffe, E. B.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S30 - S30
  • [47] Cutaneous adverse events of telaprevir/peginterferon/ribavirin therapy for chronic hepatitis C: A multicenter prospective cohort study
    Lorcy, S.
    Gaudy-Marqueste, C.
    Botta, D.
    Portal, I.
    Quiles, N.
    Oulies, V.
    Mancini, J.
    Grob, J. -J.
    Richard, M. -A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2016, 143 (05): : 336 - 346
  • [48] Thyroid diseases induced by peginterferon and ribavirin treatment in patients with chronic hepatitis C:a retrospective study
    周学士
    China Medical Abstracts (Internal Medicine), 2017, 34 (04) : 207 - 207
  • [49] Antinuclear antibody titer and treatment response to peginterferon plus ribavirin for chronic hepatitis C patients
    Hsieh, Ming-Yen
    Dai, Chia-Yen
    Lee, Li-Po
    Huang, Jee-Fu
    Chuang, Wan-Long
    Hou, Nai-Jen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Hsieh, Ming-Yuh
    Wang, Liang-Yen
    Chang, Wen-Yu
    Yu, Ming-Lung
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2012, 28 (02): : 86 - 93
  • [50] COST EFFECTIVENESS OF THE COMBINATION OF BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRIN VERSUS TELAPREVIR PLUS PEGINTERFERON ALFA AND RIBAVIRIN IN THE RETREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C VIRUS GENOTYPE I INFECTION
    Fonseca, M.
    Garran, V
    Araujo, G. T.
    VALUE IN HEALTH, 2012, 15 (07) : A329 - A329
12345